Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Autophagy: A Challengeable Paradox in Cancer Treatment Publisher Pubmed



Ahmadidehlaghi F1, 2 ; Mohammadi P1, 3 ; Valipour E4 ; Pournaghi P2 ; Kiani S1 ; Mansouri K5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Biology, Payame Noor University, Tehran, Iran
  3. 3. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran
  4. 4. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

Source: Cancer Medicine Published:2023


Abstract

Objective: Autophagy is an intracellular degradation pathway conserved in all eukaryotes from yeast to humans. This process plays a quality-control role by destroying harmful cellular components under normal conditions, maintaining cell survival, and establishing cellular adaptation under stressful conditions. Hence, there are various studies indicating dysfunctional autophagy as a factor involved in the development and progression of various human diseases, including cancer. In addition, the importance of autophagy in the development of cancer has been highlighted by paradoxical roles, as a cytoprotective and cytotoxic mechanism. Despite extensive research in the field of cancer, there are many questions and challenges about the roles and effects suggested for autophagy in cancer treatment. The aim of this study was to provide an overview of the paradoxical roles of autophagy in different tumors and related cancer treatment options. Methods: In this study, to find articles, a search was made in PubMed and Google scholar databases with the keywords Autophagy, Autophagy in Cancer Management, and Drug Design. Results: According to the investigation, some studies suggest that several advanced cancers are dependent on autophagy for cell survival, so when cancer cells are exposed to therapy, autophagy is induced and suppresses the anti-cancer effects of therapeutic agents and also results in cell resistance. However, enhanced autophagy from using anti-cancer drugs causes autophagy-mediated cell death in several cancers. Because autophagy also plays roles in both tumor suppression and promotion further research is needed to determine the precise mechanism of this process in cancer treatment. Conclusion: We concluded in this article, autophagy manipulation may either promote or hinder the growth and development of cancer according to the origin of the cancer cells, the type of cancer, and the behavior of the cancer cells exposed to treatment. Thus, before starting treatment it is necessary to determine the basal levels of autophagy in various cancers. © 2023 Medical Biology Research Center. Cancer Medicine published by John Wiley & Sons Ltd.
Other Related Docs
20. Autophagy Induction Reduces Telomerase Activity in Hela Cells, Mechanisms of Ageing and Development (2017)
26. Implications on the Therapeutic Potential of Statins Via Modulation of Autophagy, Oxidative Medicine and Cellular Longevity (2021)
29. Virus, Exosome, and Microrna: New Insights Into Autophagy, Advances in Experimental Medicine and Biology (2022)
33. Regulatory Effects of Trimetazidine in Cardiac Ischemia/Reperfusion Injury, Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
35. Programmed Cell Death and Melatonin: A Comprehensive Review, Functional and Integrative Genomics (2024)
46. Targets for Improving Tumor Response to Radiotherapy, International Immunopharmacology (2019)
47. Sestrin2 in Cancer: A Foe or a Friend?, Biomarker Research (2022)